POET Technologies (POET) Stock Soars 30% Following Major Lumilens AI Agreement

Key Highlights

• POET Technologies shares rocketed more than 10% following the announcement of a $50M opening order from Lumilens, potentially expanding beyond $500M across five years.
• A US$400M direct investment from a single institutional backer boosted the company’s cash position to $825M, enabling a 10-fold capacity expansion.
• First quarter 2026 revenues reached approximately $0.5M while net losses exceeded $12M, positioning this as a speculative growth play.
• Industry veteran Dr. Sandeep Kumar joined as Chief Operating Officer to oversee manufacturing expansion at Malaysian production partners.
• Shares initially spiked 30%+ following the Lumilens announcement before retreating roughly 10% as investors processed dilution from the fundraising.

POET Technologies (POET) has emerged as one of the most explosive momentum plays in the AI hardware sector, and recent developments clearly demonstrate why.

POET Technologies Inc., POET

The stock launched at approximately $11.98 on June 1, surged to an intraday peak of $14.37, and closed near $13.66. This volatility perfectly illustrates the market forces at work — aggressive momentum players, opportunistic dip hunters, and scrambling short sellers.

Since early April, when shares traded around $6.11, POET reached an intraday zenith of $20.81. The journey has been extraordinarily turbulent.

The primary catalyst driving attention is the Lumilens partnership. Lumilens represents a venture-funded startup, established in 2024 with backing from Mayfield and Spark Capital, developing silicon photonics and optical interconnect solutions for AI data centers and GPU infrastructure.

POET finalized a supply and technology partnership with Lumilens featuring a $50M opening purchase order for its Electrical-Optical Interposer engines. Company leadership indicates this agreement could surpass $500M throughout a five-year period.

For an enterprise generating approximately $0.5M in quarterly revenues, this represents a transformational contract.

The Lumilens leadership team brings substantial credibility. Its Chief Executive previously launched Contrail Systems and Volterra, both successfully acquired by major networking corporations. The startup has already secured hyperscaler clients, and market observers suspect POET is delivering components to at least one major player via Lumilens.

Traders responded immediately when the announcement dropped in mid-May — POET surged 30% to 39% on exceptional volume. This signified a complete reassessment of the company’s business trajectory, not merely a transient trading spike.

$400M Funding Round Delivers Power and Pressure

Shortly following the Lumilens excitement, POET secured US$400M through a registered direct placement with a single institutional participant, MMCAP, priced around $21 per unit with three-year warrants carrying a 25% premium exercise price.

Shares declined approximately 10% on this disclosure as market participants balanced dilution concerns against expanded capital resources. This tension defines the current POET investment thesis.

Following the raise, POET commands $825M in cash reserves. The organization has already allocated portions strategically — ordering equipment to boost wafer manufacturing capacity tenfold, extending a $30M loan to a company possessing desired technology, and deploying $3M into Lessengers.

Leadership has also indicated potential acquisition targets to strengthen its differentiated offering in high-speed transceivers and light source technology.

Production Expansion Becomes Priority Focus

POET’s appointment of Dr. Sandeep Kumar as Chief Operating Officer sends an unmistakable message about strategic direction. The former Silicon Labs SVP is charged with implementing semiconductor-quality manufacturing protocols across POET’s Malaysian contract manufacturing operations.

Assembly and testing functions currently operate through two Malaysian manufacturing partners. At least one partner has signaled willingness to co-fund expansion equipment for 2027 and 2028 production volumes.

Revenue-generating shipments are anticipated to commence during the latter half of 2026, although management acknowledged several weeks of schedule slippage this quarter. Additional undisclosed customer relationships are developing alongside previously announced partnerships.

POET maintains active collaborations with LITEON and Lessengers, and is pursuing U.S. redomiciliation to establish closer proximity to AI and data center customers.

The current ratio exceeds 35, debt levels remain minimal, and the $400M capital injection provides POET with substantial runway to deliver on the Lumilens contract and pursue additional opportunities.

The post POET Technologies (POET) Stock Soars 30% Following Major Lumilens AI Agreement appeared first on Blockonomi.